loader
Please Wait
Applying Filters...

Digital Content for Arfolitixorin

Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.targetedonc.com/view/arfolitixorin-lands-fda-fast-track-designation-for-advanced-crc

TARGETEDONC
26 Nov 2021

https://www.prnewswire.com/news-releases/invitation-to-a-conference-call-and-webcast-by-isofol-in-connection-with-the-entered-license-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada-301164819.html

PRNEWSWIRE
02 Nov 2020

https://www.biospace.com/article/releases/isofol-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada/#:~:text=The%20license%20agreement%20is%20focused,retain%20all%20international%20development%20rights.

BIOSPACE
02 Nov 2020

https://isofolmedical.com/isofol-enters-licensing-agreement-with-solasia-to-develop-and-commercialize-arfolitixorin-in-japan/

ISOFOLMEDICAL
17 Aug 2020

https://www.prnewswire.com/news-releases/isofol-enters-licensing-agreement-with-solasia-to-develop-and-commercialize-arfolitixorin-in-japan-301111582.html

PRNEWSWIRE
12 Aug 2020

https://www.prnewswire.com/news-releases/isofols-drug-candidate-arfolitixorin-receives-additional-clinical-patent-approval-in-the-united-states-301052612.html

PRNEWSWIRE
04 May 2020